TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Genon Biotechnologies Oy
Closing information (x1000 SEK)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
631
|
603
|
742 |
Financial expenses |
0
![]() |
0 | |
Earnings before taxes |
402
|
375
|
419 |
Total assets |
4,018
|
3,864
|
4,044 |
Current assets |
727
|
548
|
704 |
Current liabilities |
0
|
18
|
29 |
Equity capital |
4,009
|
3,837
|
4,016 |
- share capital |
77
|
73
|
76 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
99.8%
|
99.3%
![]() |
99.3% |
Turnover per employee |
316
|
302
|
371 |
Profit as a percentage of turnover |
63.7%
|
62.2%
|
56.5% |
Return on assets (ROA) |
9.7%
|
10.4% | |
Current ratio |
3044.4%
|
2427.6% | |
Return on equity (ROE) |
10.0%
|
9.8%
|
10.4% |
Change turnover |
0
|
-110 | |
Change turnover % |
0%
|
-15% | |
Chg. No. of employees |
0
![]() |
0 | |
Chg. No. of employees % |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.